Live Courses

This symposium provides up-to-date content on topics relevant in today's primary care practice environment. Attendees engage with experts sharing latest information on common diseases/conditions/issues faced by PCPs, including screening, prevention, treatment and management.This is a Jointly Provided symposium between Thomas Jefferson University and Penn Medicine. Thomas Jefferson will process all registration payments and will also handle credits. For more information and to register, click the...

This is the 32nd year for the State of the Art Arrhythmia Symposium. Using a combination of case presentations with audience participation, didactic presentations, and question and answer sessions, our goal is to educate the participants in state of the art information on invasive and non-invasive electrophysiologic and electrocardiographic tools used in the current diagnosis, evaluation and treatment of cardiac rhythm disorders. The program is taught by members of the faculty and staff from the...

The 2025 Penn Kidney Transplant Symposium will provide an overview of kidney transplantation and instruction on the kidney transplant referral and evaluation processes as well as more advanced concepts such as living donor kidney transplantation, managing mental health issues in kidney transplantation, improving access to kidney transplantation for complex patients and an overview of exciting clinical trials in kidney transplantation at Penn that can benefit kidney transplant patients.

Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephritic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and anti...

CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new therapeutic strategies for hypertension, hyperlipidemia, and CKD.

The first International Conference on Research in Williams Syndrome will take place on September 29-30, 2025 at the STUDY at University City (20 S. 33rd St, Philadelphia, PA), hosted by the Armellino Center of Excellence for Williams Syndrome (ACE-WS). ACE-WS is a comprehensive program for clinical care, research, and education for individuals with Williams syndrome across the lifespan. ACE-WS is a joint program between the University of Pennsylvania and Children’s Hospital of Philadelphia....

This program will address practical challenges in breast imaging, offering strategies to enhance image interpretation and exploring emerging technologies that support personalized or precision imaging in both screening and diagnostic settings. The course will highlight advanced imaging modalities beyond traditional mammography, including supplemental screening with ultrasound, contrast-enhanced mammography, and abbreviated breast MRI, along with the growing role of artificial intelligence in bre...